Results 51 to 60 of about 13,355 (171)
A Global Perspective of Childhood Vaccinations: Past, Present, and Future—From Smallpox to mRNA
Acta Paediatrica, EarlyView.ABSTRACT Childhood immunisation is one of the most successful public health interventions in history, preventing millions of deaths and substantially reducing global child mortality. This mini‐review summarises the historical development of childhood vaccines, the role of global coordination in expanding immunisation coverage, and the innovations that ...
Tobias Alfvén, Tania Reza, Alieu Sowe
wiley +1 more source
MMR and egg allergy: to vaccinate or not to vaccinate? [PDF]
British Journal of General Practice, 2010 We do receive a number of referrals every year (10–15) from GPs for MMR to be administered in a hospital setting. The live measles and mumps vaccine is grown on cultured chick embryo fibroblasts and there is a concern that there could be some amount of egg protein in the vaccine.
Srinivas, Bandi, Colin, Macdougall
openaire +2 more sources
Immunogenicity and Safety of a Novel MMR Vaccine (Live) (Freeze-dried): Results of a Phase II Clinical Trial [PDF]
Journal of Clinical and Diagnostic Research, 2018 Introduction: This is the first study in Indian paediatric subjects to evaluate the novel Measles, Mumps and Rubella (MMR) vaccine developed by M/s Cadila Healthcare Limited, India, containing the Hoshino mumps strain.
Rajesh Joshi +6 more
doaj +1 more source
Trained Immunity in Childhood Vaccination
Acta Paediatrica, EarlyView.Trained immunity as an emerging concept in paediatric vaccinology. Trained immunity links vaccine stimuli through epigenetic and metabolic reprogramming to enhanced innate immune cell function, thereby strengthening protection against diverse pathogens while promoting adaptive immune responses through more efficient antigen presentation and co ...
ChenRongRong Cai +2 more
wiley +1 more source
Knowledge, attitudes and opinions towards measles and the MMR vaccine across two NSW cohorts
Australian and New Zealand Journal of Public Health, 2017 Objective: Although the number of national measles cases has greatly decreased since 1980s, there has been resurgence in disease incidence in recent years. While parental knowledge and attitudes toward both disease and vaccinations are known to influence
Daniel Brieger +3 more
doaj +1 more source
Doctors' Attitudes and MMR-Vaccination
Scandinavian Journal of Primary Health Care, 1991 97 general practices, representing 171 practitioners, were asked about attitudes and certain procedures in relation to vaccination against measles, mumps, and rubella (MMR). Answers were correlated with their actual vaccination rate, calculated from the National Health Service Computer System.
openaire +2 more sources
Exploring the Development of Vaccine Platforms, With a Particular Focus on the COVID‐19 Pandemic
Acta Paediatrica, EarlyView.ABSTRACT Vaccines have been a cornerstone of human health for more than 200 years and one of the most important tools to reduce childhood deaths caused by pathogens. The concept of vaccines is basically to take something safe, make it immunogenic and induce an immune response in the host that will protect it against something dangerous. Live attenuated
Matti Sällberg
wiley +1 more source
Therapeutic Advances in Vaccines and Immunotherapy, 2022 Background: Historically, there have been many factors that have influenced mumps, measles and rubella (MMR) vaccine uptake, including media bias, social/economic determinants, parental education level, deprivation and concerns over vaccine safety ...
Tina Downey +2 more
doaj +1 more source
CRISPR, APGAR and Cancer Screening: Public Engagement, Controversy and Misaligned Values
Bioethics, EarlyView.ABSTRACT There are many calls for public engagement in decision‐making around controversial technologies, but far fewer calls for public engagement in deliberation around less controversial interventions. We think the public should be involved in discussing CRISPR, but not in discussing APGAR.
Stephen John
wiley +1 more source
The Turkish Journal of Pediatrics, 2000 A total of 44 children aged between 15-18 months were randomly vaccinated either with a new measles-mumps-rubella (MMR) vaccine (Priorix, SmithKline Beecham) or a commercially available MMR vaccine (MMR-II, Merck) to compare the reactogenicity and
G Kanra, M Ceyhan, E Ozmert
doaj